Egleston Brian L, Uzzo Robert G, Wong Yu-Ning
Chairman of Surgery, Fox Chase Cancer Center, Temple University Health System.
Medical Oncology, Fox Chase Cancer Center, Temple University Health System.
J Am Stat Assoc. 2017;112(518):534-546. doi: 10.1080/01621459.2016.1240078. Epub 2016 Oct 7.
Rates of kidney cancer have been increasing, with small incidental tumors experiencing the fastest growth rates. Much of the increase could be due to increased use of CT scans, MRIs, and ultrasounds for unrelated conditions. Many tumors might never have been detected or become symptomatic in the past. This suggests that many patients might benefit from less aggressive therapy, such as active surveillance by which tumors are surgically removed only if they become sufficiently large. However, it has been difficult for clinicians to identify subgroups of patients for whom treatment might be especially beneficial or harmful. In this work, we use a principal stratification framework to estimate the proportion and characteristics of individuals who have large or small hazard rates of death in two treatment arms. This allows us to assess who might be helped or harmed by aggressive treatment. We also use Weibull mixture models. This work differs from much previous work in that the survival classes upon which principal stratification is based are latent variables. That is, survival class is not an observed variable. We apply this work using Surveillance Epidemiology and End Results-Medicare claims data. Clinicians can use our methods for investigating treatments with heterogeneous effects.
肾癌发病率一直在上升,其中小的偶然发现的肿瘤增长速度最快。发病率的上升很大程度上可能是由于对无关病症增加使用CT扫描、核磁共振成像和超声检查。过去,许多肿瘤可能从未被检测到或出现症状。这表明许多患者可能从不太激进的治疗中获益,比如主动监测,即只有当肿瘤足够大时才通过手术切除。然而,临床医生很难识别出哪些患者亚组可能从治疗中特别受益或受到伤害。在这项研究中,我们使用主分层框架来估计在两种治疗方案中死亡风险率高或低的个体比例及特征。这使我们能够评估谁可能因积极治疗而受益或受到伤害。我们还使用威布尔混合模型。这项研究与之前的许多研究不同之处在于,主分层所基于的生存类别是潜在变量。也就是说,生存类别不是一个可观察的变量。我们使用监测、流行病学和最终结果-医疗保险理赔数据来开展这项研究。临床医生可以使用我们的方法来研究具有异质性效应的治疗方法。